8. Genetikk

Bishop, D. T., Demenais, F., Goldstein, A. M., Bergman, W., Bishop, J. N., Bressac-de Paillerets, B., Chompret, A., Ghiorzo, P., ... Melanoma Genetics Consortium (2002). Geographical variation in the penetrance of CDKN2A mutations for melanoma. Journal of the National Cancer Institute, 94(12), 894-903.

Bishop, D. T., Demenais, F., Iles, M. M., Harland, M., Taylor, J. C., Corda, E., Randerson-Moor, J., Aitken, J. F., ... Bishop, J. A. (2009). Genome-wide association study identifies three loci associated with melanoma risk. Nature genetics, 41(8), 920-5.

Bishop, J. N., Bataille, V., Gavin, A., Lens, M., Marsden, J., Mathews, T., & Wheelhouse, C. (2007). The prevention, diagnosis, referral and management of melanoma of the skin: concise guidelines. Clinical medicine (London, England), 7(3), 283-90.

Bishop, J. N., Harland, M., Randerson-Moor, J., & Bishop, D. T. (2007). Management of familial melanoma. The Lancet. Oncology, 8(1), 46-54.

Carbone, M., Yang, H., Pass, H. I., Krausz, T., Testa, J. R., & Gaudino, G. (2013). BAP1 and cancer. Nature reviews. Cancer, 13(3), 153-9.

Goldstein, A. M., Struewing, J. P., Chidambaram, A., Fraser, M. C., & Tucker, M. A. (2000). Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations. Journal of the National Cancer Institute, 92(12), 1006-10.

Hansson, J., Bergenmar, M., Hofer, P. A., Lundell, G., Mansson-Brahme, E., Ringborg, U., Synnerstad, I., Bratel, A. T., ... Rosdahl, I. (2007). Monitoring of kindreds with hereditary predisposition for cutaneous melanoma and dysplastic nevus syndrome: results of a Swedish preventive program. Journal of clinical oncology, 25(19), 2819-24.

Helsing, P., Nymoen, D. A., Ariansen, S., Steine, S. J., Maehle, L., Aamdal, S., Langmark, F., Loeb, M., ... Andresen, P. A. (2008). Population-based prevalence of CDKN2A and CDK4 mutations in patients with multiple primary melanomas. Genes, chromosomes & cancer, 47(2), 175-84.

Landi, S. (2009). Genetic predisposition and environmental risk factors to pancreatic cancer: A review of the literature. Mutation research, 681(2-3), 299-307.

Lynch, H. T., Fusaro, R. M., Lynch, J. F., & Brand, R. (2008). Pancreatic cancer and the FAMMM syndrome. Familial cancer, 7(1), 103-12.

Meyle, K. D., & Guldberg, P. (2009). Genetic risk factors for melanoma. Human genetics, 126(4), 499-510.

Molven, A., Grimstvedt, M. B., Steine, S. J., Harland, M., Avril, M. F., Hayward, N. K., & Akslen, L. A. (2005). A large Norwegian family with inherited malignant melanoma, multiple atypical nevi, and CDK4 mutation. Genes, chromosomes & cancer, 44(1), 10-8.

Toussi, A., Mans, N., Welborn, J., & Kiuru, M. (2020). Germline mutations predisposing to melanoma. Journal of cutaneous pathology, 47(7), 606-616.